PDB Short entry for 3F81 HEADER HYDROLASE 11-NOV-08 3F81 TITLE INTERACTION OF VHR WITH SA3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN PHOSPHATASE 3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 3-185; COMPND 5 SYNONYM: DUAL SPECIFICITY PROTEIN PHOSPHATASE VHR; COMPND 6 EC: 3.1.3.48, 3.1.3.16; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DUSP3, VHR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-1 KEYWDS HYDROLASE, PROTEIN DUAL-SPECIFICITY PHOSPHATASE, INHIBITOR, PROTEIN KEYWDS 2 PHOSPHATASE EXPDTA X-RAY DIFFRACTION AUTHOR S.WU,T.MUTELIN,L.TAUTZ REVDAT 4 06-SEP-23 3F81 1 REMARK REVDAT 3 19-FEB-20 3F81 1 COMPND REMARK HETNAM FORMUL REVDAT 2 17-NOV-09 3F81 1 JRNL REVDAT 1 10-NOV-09 3F81 0 JRNL AUTH S.WU,S.VOSSIUS,S.RAHMOUNI,A.V.MILETIC,T.VANG, JRNL AUTH 2 J.VAZQUEZ-RODRIGUEZ,F.CERIGNOLI,Y.ARIMURA,S.WILLIAMS, JRNL AUTH 3 T.HAYES,M.MOUTSCHEN,S.VASILE,M.PELLECCHIA,T.MUSTELIN,L.TAUTZ JRNL TITL MULTIDENTATE SMALL-MOLECULE INHIBITORS OF VACCINIA JRNL TITL 2 H1-RELATED (VHR) PHOSPHATASE DECREASE PROLIFERATION OF JRNL TITL 3 CERVIX CANCER CELLS. JRNL REF J.MED.CHEM. V. 52 6716 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19888758 JRNL DOI 10.1021/JM901016K REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 26330 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1408 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1922 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.1840 REMARK 3 BIN FREE R VALUE SET COUNT : 106 REMARK 3 BIN FREE R VALUE : 0.2360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2784 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 219 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.79000 REMARK 3 B22 (A**2) : -0.49000 REMARK 3 B33 (A**2) : -0.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.58000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.160 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.144 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.087 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.807 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2856 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3862 ; 1.724 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 356 ; 9.920 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;38.973 ;24.706 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 500 ;15.395 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;17.852 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 428 ; 0.247 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2174 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1405 ; 0.223 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1948 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 214 ; 0.153 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 52 ; 0.213 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.273 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1837 ; 0.912 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2854 ; 1.464 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1145 ; 2.541 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1008 ; 4.051 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 7 A 185 4 REMARK 3 1 B 7 B 185 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1392 ; 0.57 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1392 ; 0.98 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3F81 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050262. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-06 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26330 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 1VHR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS 15% POLYETHYLENE GLYCOL REMARK 280 8000, 60 MM NAF, PH 7.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 297.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.59300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 29.59300 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 41.58708 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 29.59300 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 60.01147 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 PHE A 5 REMARK 465 GLU A 6 REMARK 465 GLY B 3 REMARK 465 SER B 4 REMARK 465 PHE B 5 REMARK 465 GLU B 6 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 104 CG ARG A 104 CD 0.241 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 104 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 SER B 8 N - CA - C ANGL. DEV. = -16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 124 -146.80 -137.25 REMARK 500 SER A 129 -57.05 -123.75 REMARK 500 CYS B 124 -143.29 -138.47 REMARK 500 SER B 129 -58.26 -122.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 114 GLN A 115 135.00 REMARK 500 LEU B 7 SER B 8 -78.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 LIGAND STT IN THIS PDB FILE REFERS TO SA3 IN CITATION. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 STT A 1 REMARK 610 STT B 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STT A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STT B 1 DBREF 3F81 A 3 185 UNP P51452 DUS3_HUMAN 3 185 DBREF 3F81 B 3 185 UNP P51452 DUS3_HUMAN 3 185 SEQRES 1 A 183 GLY SER PHE GLU LEU SER VAL GLN ASP LEU ASN ASP LEU SEQRES 2 A 183 LEU SER ASP GLY SER GLY CYS TYR SER LEU PRO SER GLN SEQRES 3 A 183 PRO CYS ASN GLU VAL THR PRO ARG ILE TYR VAL GLY ASN SEQRES 4 A 183 ALA SER VAL ALA GLN ASP ILE PRO LYS LEU GLN LYS LEU SEQRES 5 A 183 GLY ILE THR HIS VAL LEU ASN ALA ALA GLU GLY ARG SER SEQRES 6 A 183 PHE MET HIS VAL ASN THR ASN ALA ASN PHE TYR LYS ASP SEQRES 7 A 183 SER GLY ILE THR TYR LEU GLY ILE LYS ALA ASN ASP THR SEQRES 8 A 183 GLN GLU PHE ASN LEU SER ALA TYR PHE GLU ARG ALA ALA SEQRES 9 A 183 ASP PHE ILE ASP GLN ALA LEU ALA GLN LYS ASN GLY ARG SEQRES 10 A 183 VAL LEU VAL HIS CYS ARG GLU GLY TYR SER ARG SER PRO SEQRES 11 A 183 THR LEU VAL ILE ALA TYR LEU MET MET ARG GLN LYS MET SEQRES 12 A 183 ASP VAL LYS SER ALA LEU SER ILE VAL ARG GLN ASN ARG SEQRES 13 A 183 GLU ILE GLY PRO ASN ASP GLY PHE LEU ALA GLN LEU CYS SEQRES 14 A 183 GLN LEU ASN ASP ARG LEU ALA LYS GLU GLY LYS LEU LYS SEQRES 15 A 183 PRO SEQRES 1 B 183 GLY SER PHE GLU LEU SER VAL GLN ASP LEU ASN ASP LEU SEQRES 2 B 183 LEU SER ASP GLY SER GLY CYS TYR SER LEU PRO SER GLN SEQRES 3 B 183 PRO CYS ASN GLU VAL THR PRO ARG ILE TYR VAL GLY ASN SEQRES 4 B 183 ALA SER VAL ALA GLN ASP ILE PRO LYS LEU GLN LYS LEU SEQRES 5 B 183 GLY ILE THR HIS VAL LEU ASN ALA ALA GLU GLY ARG SER SEQRES 6 B 183 PHE MET HIS VAL ASN THR ASN ALA ASN PHE TYR LYS ASP SEQRES 7 B 183 SER GLY ILE THR TYR LEU GLY ILE LYS ALA ASN ASP THR SEQRES 8 B 183 GLN GLU PHE ASN LEU SER ALA TYR PHE GLU ARG ALA ALA SEQRES 9 B 183 ASP PHE ILE ASP GLN ALA LEU ALA GLN LYS ASN GLY ARG SEQRES 10 B 183 VAL LEU VAL HIS CYS ARG GLU GLY TYR SER ARG SER PRO SEQRES 11 B 183 THR LEU VAL ILE ALA TYR LEU MET MET ARG GLN LYS MET SEQRES 12 B 183 ASP VAL LYS SER ALA LEU SER ILE VAL ARG GLN ASN ARG SEQRES 13 B 183 GLU ILE GLY PRO ASN ASP GLY PHE LEU ALA GLN LEU CYS SEQRES 14 B 183 GLN LEU ASN ASP ARG LEU ALA LYS GLU GLY LYS LEU LYS SEQRES 15 B 183 PRO HET STT A 1 14 HET STT B 1 14 HETNAM STT 2-[(5~{E})-5-[[3-[4-(2-FLUORANYLPHENOXY)PHENYL]-1- HETNAM 2 STT PHENYL-PYRAZOL-4-YL]METHYLIDENE]-4-OXIDANYLIDENE-2- HETNAM 3 STT SULFANYLIDENE-1,3-THIAZOLIDIN-3-YL]ETHANESULFONIC ACID FORMUL 3 STT 2(C27 H20 F N3 O5 S3) FORMUL 5 HOH *219(H2 O) HELIX 1 1 LEU A 7 SER A 17 1 11 HELIX 2 2 ASN A 41 GLN A 46 1 6 HELIX 3 3 ASP A 47 GLY A 55 1 9 HELIX 4 4 ALA A 75 LYS A 79 5 5 HELIX 5 5 ASN A 97 ALA A 100 5 4 HELIX 6 6 TYR A 101 GLN A 115 1 15 HELIX 7 7 SER A 129 LYS A 144 1 16 HELIX 8 8 ASP A 146 ARG A 158 1 13 HELIX 9 9 ASN A 163 GLU A 180 1 18 HELIX 10 10 LEU B 7 SER B 17 1 11 HELIX 11 11 ASN B 41 GLN B 46 1 6 HELIX 12 12 ASP B 47 GLY B 55 1 9 HELIX 13 13 ALA B 75 LYS B 79 5 5 HELIX 14 14 ASN B 97 ALA B 100 5 4 HELIX 15 15 TYR B 101 GLN B 115 1 15 HELIX 16 16 SER B 129 GLN B 143 1 15 HELIX 17 17 ASP B 146 ARG B 158 1 13 HELIX 18 18 ASN B 163 GLY B 181 1 19 SHEET 1 A 5 CYS A 30 THR A 34 0 SHEET 2 A 5 ILE A 37 GLY A 40 -1 O VAL A 39 N ASN A 31 SHEET 3 A 5 VAL A 120 HIS A 123 1 O VAL A 122 N TYR A 38 SHEET 4 A 5 HIS A 58 ASN A 61 1 N LEU A 60 O LEU A 121 SHEET 5 A 5 THR A 84 GLY A 87 1 O LEU A 86 N ASN A 61 SHEET 1 B 5 CYS B 30 THR B 34 0 SHEET 2 B 5 ILE B 37 GLY B 40 -1 O ILE B 37 N THR B 34 SHEET 3 B 5 VAL B 120 HIS B 123 1 O VAL B 120 N TYR B 38 SHEET 4 B 5 HIS B 58 ASN B 61 1 N LEU B 60 O LEU B 121 SHEET 5 B 5 THR B 84 GLY B 87 1 O THR B 84 N VAL B 59 SITE 1 AC1 9 MET A 69 ASP A 92 CYS A 124 ARG A 125 SITE 2 AC1 9 GLU A 126 TYR A 128 SER A 129 ARG A 130 SITE 3 AC1 9 GLN B 115 SITE 1 AC2 11 ASN A 117 MET B 69 ASP B 92 CYS B 124 SITE 2 AC2 11 ARG B 125 GLU B 126 TYR B 128 SER B 129 SITE 3 AC2 11 ARG B 130 HOH B 240 HOH B 307 CRYST1 50.406 59.186 60.656 90.00 98.36 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019839 0.000000 0.002917 0.00000 SCALE2 0.000000 0.016896 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016664 0.00000